References
- Kapiteijn E, Marijnen CA, Nagtegaal ID, Putter H, Steup WH, Wiggers T, et al. Preoperative radiotherapy combined with total mesorectal excision for resectable rectal cancer. N Engl J Med 2001; 345: 638–46
- Glimelius B, Gronberg H, Jarhult J, Wallgren A, Cavallin-Ståhl E. A systematic overview of radiation therapy effects in rectal cancer. Acta Oncol 2003; 42: 476–92
- Widder J, Herbst F, Dobrowsky W, Schmid R, Pokrajac B, Jech B, et al. Preoperative short-term radiation therapy (25Gy, 2.5 Gy twice daily) for primary resectable rectal cancer (phase II). Br J Cancer 2005; 92: 1209–14
- Sauer R, Becker H, Hohenberger W, Rodel C, Wittekind C, Fietkau R, et al. Preoperative versus postoperative chemoradiotherapy for rectal cancer. N Engl J Med 2004; 351: 1731–40
- Scheithauer W, Kornek GV, Raderer M, Schull B, Schmid K, Kovats E, et al. Randomized multicenter phase II trial of two different schedules of capecitabine plus oxaliplatin as first-line treatment in advanced colorectal cancer. J Clin Oncol 2003; 21: 1307–12
- Widder J, Sedlmayer F, Stanek C, Pötter R. Quality assurance in preoperative radiotherapy of rectal cancer: evaluation of a pre-trial dummy run. Radiother Oncol 2000; 56: 341–7
- Rodel C, Grabenbauer GG, Papadopoulos T, Hohenberger W, Schmoll HJ, Sauer R. Phase I/II trial of capecitabine, oxaliplatin and radiation for rectal cancer. J Clin Oncol 2003; 21: 3098–104
- Valentini V, Coco C, Picciocchi A, Morganti AG, Trodella L, Ciabattoni A, et al. Does downstaging predict improved outcome after preoperative chemoradiation for extraperitoneal locally advanced rectal cancer? A long-term analysis of 165 patients. Int J Radiat Oncol Biol Phys 2002; 53: 664–74